Sanjivani Paranteral Ltd Share Price

Q: What is the share price of Sanjivani Paranteral Ltd today?

Sanjivani Paranteral Ltd share price as on 18 Nov 2025 is ₹181.8

Pharmaceuticals

BSE: 531569 Small Cap ISIN: INE860D01013

As on 18 November 2025 at 23:53 IST

₹181.80

-7.35

(-3.89%)

Sell Buy

Over 1 Month

-10.67%

Over 6 Months

-15.52%

Over 1 Year

-36.07%

Over 3 Years

321.27%

Sanjivani Paranteral Ltd Summary

Close ₹189.15

Open ₹195.60

High ₹195.60

Low ₹170

Volume 32,833

Net Turnover (in Cr) ₹0.59

52Wk High ₹396.95

52Wk Low ₹170

52Wk High / Low

170

396.95

Sanjivani Paranteral Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹232.36

EPS (TTM) 6.07

Book Value (BV) 36.50

Div. Yield 0.26 %

P/E (TTM) 31.16

Price/Book Value 5.18

Delivery % 66.10 %

Face Value 10

Key Ratios

PE Ratio 35.15

PB Ratio 7.77

EV to Sales 4.12

PEG Ratio 1.21

ROA 18.37

ROE 10.15

Debt-Equity 0.10

Net Profit Margin 11.55

Operating Profit Margin 16.50

Sanjivani Paranteral Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Total Revenue	71.31	54.93
Total Expenses	60.96	47.36
Profit Before Tax	10.35	7.57
Profit After Tax	8.09	6.17
Operating Profit After Depreciation	10.95	7.83

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Fixed Assets	20.64	9.94
Total Non Current Assets	44.02	14.77
Total Current Assets	34.18	28.64
Total Assets	78.20	43.41
Total Shareholder's Fund	38	27.90

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Net Cash From Operating Activities	12.40	-10.70
Net Cash Used In Investing Activities	-21.91	-12.21
Net Cash Used In Financing Activities	10.46	23.16

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	71.31	54.93	36.05	30.86	25.36
Total Expenses	60.95	47.36	31.10	25.98	23.95
Profit Before Tax	10.36	7.57	4.94	4.88	1.41
Profit After Tax	8.10	6.17	4.51	4.85	1.42
Operating Profit After Depreciation	10.95	7.83	5.30	5.09	1.54

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	20.56	9.94	7.57	7.42	7.62
Total Non Current Assets	26.89	14.77	12.74	10.57	10.09
Total Current Assets	38.10	28.64	8.27	7.73	9.18
Total Assets	65	43.41	21.01	18.30	19.28
Total Shareholder's Fund	38	27.90	-3.07	-7.58	-44.89

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-0.24	-10.70	4.68	8.52	0.58
Net Cash Used In Investing Activities	-5.81	-12.21	-0.99	-0.67	-0.42
Net Cash Used In Financing Activities	6.14	23.16	-3.73	-7.68	-0.26

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	15.50	17.89	18.18	17.35	18.13
Total Expenses	13.25	15.25	15.57	14.80	15.27
Profit Before Tax	2.19	2.30	2.66	2.51	2.92
Profit After Tax	1.64	1.73	2.19	1.90	2.30
Operating Profit after Depreciation	2.41	2.68	3.04	2.86	3.25

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	15.50	17.89	18.18	17.35	18.13
Total Expenses	13.25	15.25	15.56	14.80	15.27
Profit Before Tax	2.19	2.30	2.67	2.51	2.92
Profit After Tax	1.64	1.73	2.19	1.90	2.30
Operating Profit after Depreciation	2.41	2.68	3.05	2.86	3.25

Sanjivani Paranteral Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 174.23

S2 159.32

S3 148.63

Pivot 184.92

R1 199.83

R2 210.52

R3 225.43

Moving Average

20 SMA 205.32

50 SMA 220.56

100 SMA 222.10

200 SMA 239.51

Sanjivani Paranteral Ltd Corporate Actions

Sanjivani Paranteral Ltd

₹0.5/Share

Announcement Date 19 Sep 2025

Record Date 19 Sep 2025

Div Yield 5%

AGM Date: 28 Sep 2021

Sanjivani Paranteral Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 20, 2021 to September 28, 2021 (both days inclusive) for the purpose of 27th Annual General Meeting (AGM) of the Company to be held on September 28, 2021. Summary of proceedings of 27th Annual General Meeting of the Company held on September 28 2021 Submission of Outcome of AGM and Scrutinizers Report Submission of Scrutinizers Report (As Per BSE Announcement Dated on 9/28/2021 4:41:12 AM)

AGM Date: 27 Sep 2022

AGM 27/09/2022 Register of Members & Share Transfer Books of the Company will remain closed from Tuesday, 20th September, 2022 to Tuesday 27th September, 2022 (both days inclusive) for updating the records of the Company for Annual General Meeting to be held on Tuesday, 27th September 2022. (As per BSE Announcement Dated on 7/9/2022) Summary of proceedings of 28th Annual General Meeting of the Company held on September 27, 2022 Submission of Scrutinizer's Report (As Per BSE Announcement dated on 27.09.2022)

AGM Date: 27 Sep 2023

We hereby submits the Annual Report of the Company for the Financial Year 2022-23 along with Notice convening the 29th Annual General Meeting which will be held on Wednesday, 27th September, 2023. Summary of proceedings of 29th Annual General Meeting of the Company held on September 27, 2023 Submission of outcome of AGM Submission of Scrutinizer''s Report (As per BSE Announcement Dated on 27/09/2023)

AGM Date: 24 Sep 2024

The 30th Annual General Meeting of the Company will be held on Tuesday, 24th September, 2024 through Video Conferencing and Other Audio-Visual Means at 11:00 A.M Proceeding of 30th Annual General Meeting (As Per BSE Announcement Dated on 24.09.2024) Scrutinizer Report of the 30th Annual General Meeting (As per BSE Announcement Dated on 25/09/2024)

AGM Date: 26 Sep 2025

Notice convening the 31st Annual General Meeting ofthe Company, proposed to be held on Friday, 26th September, 2025, through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). Dividend and e-voting record date for the 31st AGM (As per BSE Announcement Dated on 05.09.2025) 31st Annual General Meeting proceeding (As Per BSE Announcement Dated on: 26/09/2025) Scrutinizer '' Report of the 31st Annual General Meeting (As Per BSE Announcement Dated on: 27/09/2025)

EGM Date: 24 Dec 2020

We wish to inform that the Company is seeking consent of its Members to consider and pass following matters by way of remote electronic voting (E-Voting): Sr. No. Businesses to be considered in EGM Resolution required 1. To Increase the Authorised Share Capital and Consequent Alteration of the Memorandum of Association Ordinary Resolution 2. To offer, issue and allot equity shares on preferential basis Special Resolution In this regard, please find enclosed herewith, the 'Notice of the EGM' together with the Explanatory Statement. The EGM to be held on Thursday, December 24, 2020 at 11.00 a.m. (IST), through Video Conference / Other Audio Visual Means without the physical presence of Members at a common venue. This is in continuation of our letter dated November 28, 2020, with regard to submission of Notice convening the Extraordinary General Meeting ('EGM') of the Members of Sanjivani Parenteral Limited ('Company'). Please find enclosed copies of newspaper advertisements published on December 2, 2020 in a) The Free Press Journal b) Mumbai Lakshdeep confirming dispatch of Notice of EGM and remote e-voting information. (AS Per BSE Announcement Dated on 03.12.2020) The Extraordinary General Meeting ('EGM') of the Members of Sanjivani Parenteral Limited ('Company') was held on Thursday, December 24, 2020 through video conferencing, to transact the business as stated in the EGM Notice dated November 24, 2020. In compliance with Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we submit the outcome of the EGM : The Members at the EGM has approved the following: 1. Increase in the authorized share capital of the Company and consequent amendment to the Company's Memorandum of Association; and 2. Issue of Equity Shares on Preferential Basis to Mr. Ashwani Khemka and Next Orbit Ventures Fund. Please take the above on record and acknowledge receipt of the same. Pursuant to Section 108 of the Companies Act, 2013 read with Rule 20(4) of the Companies (Management and Administration) Rules, 2014, the Scrutinizer''s Report on Remote e-Voting and voting by electronic means during the EGM. (As Per BSE Announcement Dated on 24.12.2020) We hereby inform that pursuant to the Special Resolution passed by the Shareholders of Sanjivani Parenteral Limited ('Company') in the Extraordinary General Meeting held on December 24, 2020 on issuance of Equity Shares on Preferential Basis, the Board of Directors of the Company at its meeting held today, i.e., January 21, 2021, approved the allotment of 26,00,000 (Twenty Six Lakhs) equity shares of face value of Rs. 10 each ('Equity Share') at a price of Rs. 10 (Indian Rupees Ten) per Equity Share (including a premium of Rs. nil per Equity Share) on a preferential basis, for an aggregate amount of Rs. 2,60,00,000 (Indian Rupees Two Crore, Sixty Lakh) (As Per BSE Announcement Dated on 21.01.2021)

EGM Date: 26 Jul 2021

EGM 26/07/2021 We wish to inform that the Company is seeking consent of its Members to consider and pass following matters by way of remote electronic voting (E-Voting) 01. To offer, issue and allot equity shares on preferential basis In this regard, please find enclosed herewith, the 'Notice of the EGM' together with the Explanatory Statement. The EGM to be held on Monday, July 26, 2021 at 11.00 a.m. (IST), through Video Conference / Other Audio Visual Means without the physical presence of Members at a common venue. (As Per BSE Announcement Dated 01.07.2021) The Extraordinary General Meeting ('EGM') of the Members of Sanjivani Parenteral Limited ('Company') was held on Monday, July 26, 2021 through video conferencing, to transact the business as stated in the EGM Notice dated June 30, 2021. In compliance with Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we submit the outcome of the EGM as Annexure I. a) The Members at the EGM has approved the Issue of Equity Shares on Preferential Basis to a) Mr. Ashwani Khemka (Promoter category); and b) Next Orbit Ventures Fund (a SEBI Registered Venture Fund, Non-promoter category); and c) Other Investors (Non-promoter category) Please take the above on record and acknowledge receipt of the same. Pursuant to Section 108 of the Companies Act, 2013 read with Rule 20(4) of the Companies (Management and Administration) Rules, 2014, the Scrutinizer''s Report on Remote e-Voting and voting by electronic means during the EGM. The Extraordinary General Meeting ('EGM') of the Members of Sanjivani Parenteral Limited ('Company') was held on Monday, July 26, 2021 through video conferencing, to transact the business as stated in the EGM Notice dated June 30, 2021. In this regard, please find attached the summary of the proceedings of the EGM pursuant to Regulation 30 read with Part A of Schedule - III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Please take the above on record and acknowledge receipt of the same. Sanjivani Paranteral Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated on 27.07.2021)

EGM Date: 18 Jan 2024

Please find enclosed copies of newspaper advertisement of notice to shareholders for EGM to be held on January 18, 2023. Please refer attachment (As Per BSE Announcement Dated on 25.12.2023) Please refer attached EGM notice. (As Per BSE Announcement dated on 27.12.2023) Please find Outcome of EGM held on 18th January 2024 . (As Per BSE Announcement dated on 18.01.2024) Report of Scrutinzer on Remote e-voting and e-voting conducted at the Extra Ordinary General Meeting (EGM) of the Company held on Thursday, January 18, 2024. Report on Scrutinizer on Remote e-voting and e-voting conducted at the Extra Ordinary General Meeting (EGM) of the Company held on Thursday, January 18, 2024. (As Per BSE Announcement Dated on 19/01/2024)

Sanjivani Paranteral Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Sanjivani Paranteral Ltd Top Mutal Funds Invested

No data available

Sanjivani Paranteral Ltd News

Sanjivani Paranteral announces board meeting date

On 14 November 2025

08 Nov 2025, 02:11 pm

Sanjivani Paranteral schedules AGM

On 26 September 2025

20 Aug 2025, 09:50 am

Sanjivani Paranteral to declare Quarterly Results

On 12 August 2025

09 Aug 2025, 10:44 am

Board of Sanjivani Paranteral recommends final dividend

Of Rs 0.5 per share

27 May 2025, 01:48 pm

Sanjivani Paranteral to discuss results

On 27 May 2025

22 May 2025, 07:45 pm

Sanjivani Paranteral Ltd Stock Analysis

Annual revenue for Sanjivani Paranteral Ltd increased by 29.83% to ₹71.31 crore in FY 2025 from ₹54.93 crore in FY 2024.
Annual Net Profit for Sanjivani Paranteral Ltd increased by 31.41% to ₹8.10 crore in FY 2025 from ₹6.17 crore in FY 2024.
Promoter Shareholding in Sanjivani Paranteral Ltd remains unchanged by 0.00% in the most recent quarter, from 31.20% in September 2025 to 31.20% in September 2025.
Sanjivani Paranteral Ltd delivered a 1-year return of -36.07% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Sanjivani Paranteral Ltd share price moved down by 3.89% from its previous close of INR ₹189.15. The latest Sanjivani Paranteral Ltd share price is INR ₹181.80.
Sanjivani Paranteral Ltd share price today has been at a low of 181 and a high of 184. Over the past 52 weeks, the Sanjivani Paranteral Ltd share price has seen a low of 170 and a high of 396.95.